⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL577819 | 0.93 | — | — | |
| SCHEMBL7863908 | 0.90 | — | — | |
| SCHEMBL7864327 | 0.90 | — | — | |
| SCHEMBL3241432 | 0.90 | — | — | |
| SCHEMBL5498216 | 0.90 | — | — | |
| SCHEMBL7867106 | 0.90 | — | — | |
| SCHEMBL7862049 | 0.90 | — | — | |
| SCHEMBL183428 | 0.77 | — | — | |
| SCHEMBL5599721 | 0.76 | — | — | |
| SCHEMBL2866023 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 190 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1905774-B1 | Fused heterocyclic compounds as serotonin receptor modulators | JANSSEN PHARMACEUTICA NV (BE) | 2013-02-20 | — | — | EP | claimed |
| EP-1928461-B1 | PYRIMIDINE COMPOUNDS AS SEROTONIN RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2012-01-04 | — | — | EP | claimed |
| US-20110040088-A1 | FUSED HETEROCYCLIC COMPOUNDS | JANSSEN PHARMACEUTICA NV (BE) | 2011-02-17 | — | — | US | claimed |
| US-20100016281-A1 | PYRIMIDINE COMPOUNDS AS SEROTONIN RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2010-01-21 | — | — | US | claimed |
| US-20090270370-A1 | FUSED HETEROCYCLIC COMPOUNDS | JANSSEN PHARMACEUTICA NV (BE) | 2009-10-29 | — | — | US | claimed |
| EP-1668014-B1 | FUSED HETEROCYCLIC COMPOUNDS AS SEROTONIN RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2009-01-14 | — | — | EP | claimed |
| US-7402680-B2 | Fused heterocyclic compounds | JANSSEN PHARMACEUTICA, N.V. (BE) | 2008-07-22 | — | — | US | claimed |
| EP-1944306-A1 | Fused heterocyclic compounds as serotonin receptor modulators | Janssen Pharmaceutica, N.V. (BE) | 2008-07-16 | — | — | EP | claimed |
| EP-1928461-A1 | PYRIMIDINE COMPOUNDS AS SEROTONIN RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-06-11 | — | — | EP | claimed |
| US-20080103132-A1 | FUSED HETEROCYCLIC COMPOUNDS | JANSSEN PHARMACEUTICA NV (BE) | 2008-05-01 | — | — | US | claimed |
| US-20050119295-A1 | Fused heterocyclic compounds | JANSSEN PHARMACEUTICA, N.V. (BE) | 2005-06-02 | — | — | US | claimed |
| WO-2005040169-A2 | FUSED HETEROCYCLIC COMPOUNDS AS SEROTONIN RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA, N.V. (BE) | 2005-05-06 | — | — | WO | claimed |
| US-6245945-B1 | REACTING MIXTURE COMPRISING PHTHALIDE AND ACETAL OR KETAL AT FROM 10 TO 200 DEGREES C. IN PRESENCE OF FROM 1 TO 10 MOL OF WATER, BASED ON AMOUNT OF ACETAL OR KETAL, TO HYDROLYZE ACETAL OR KETAL TO CORRESPONDING ALDEHYDE OR KETONE | BASF AKTIENGESELLSCHAFT (DE) | 2001-06-12 | — | — | US | claimed |
| US-5112834-A | Antisecretory and antiulcer | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1992-05-12 | — | — | US | claimed |
| EP-0370056-A1 | NEW DIAZOLS | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1990-05-30 | — | — | EP | claimed |
| WO-1989000570-A1 | NEW DIAZOLS | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1989-01-26 | — | — | WO | claimed |
| EP-0299470-A1 | Imidazo[1,2-a]pyridines | Byk Gulden Lomberg Chemische Fabrik GmbH (DE) | 1989-01-18 | — | — | EP | claimed |
| US-4683228-A | Guanidinopyrazolylamides, guanidimoimidazolylamides, compositions containing them, and method of using them to inhibit gastric acid secretion | ICI AMERICAS INC. (US) | 1987-07-28 | — | — | US | claimed |
| EP-0150099-A1 | Guanidine derivatives | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1985-07-31 | — | — | EP | claimed |
| US-3963714-A | Quaternary ammonium salts | BASF AKTIENGESELLSCHAFT (DT) | 1976-06-15 | — | — | US | claimed |